ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

Bajaj Finserv Healthcare Fund

BAJAJ Bajaj Finserv Mutual Fund Dec 2024 — Sep 2026 22 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹387 CrAt NSE closes, Sep 2026
Companies held3333 with an NSE price
Top 10 holdings62.0%Of the equity shown here
Largest holding10.2%Divi's Laboratories Limited
12-month turnover45.9%Estimated from 12 monthly disclosures · compare

Days to sell half: 1.1 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

22 priced months, Dec 2024 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

62.0% now, 50.5% in Sep 2025 · highest 77.2%, lowest 48.7%

Companies held

33 now, 41 in Sep 2025 · largest single holding 10.2% of equity

How long new positions last: of the 21 companies this fund started holding between Jan 2025 and Sep 2025, 67% were still held a year later — it usually keeps what it buys. Across active funds the figure is about 50%, and a fund’s figure has stayed similar from year to year. A description of how the fund is run, not of its results. How this was tested →

How it trades: no clear lean toward recent winners or losers (score +0.08 over 11 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 24 shared61.7%
  2. ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 16 shared58.3%
  3. ICICI Prudential Nifty Healthcare ETFICICI Prudential · 16 shared58.3%
  4. DSP Nifty Healthcare ETFDSP · 16 shared58.3%
  5. DSP Nifty Healthcare Index FundDSP · 16 shared58.3%
  6. Axis NIFTY Healthcare ETFAxis · 16 shared58.3%
  7. Mirae Asset Healthcare FundMirae Asset · 18 shared57.5%
  8. EODWHFEdelweiss · 16 shared57.1%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 1 Companies added
Complete exits 2 Companies sold out
Increases 2 More shares than last month
Reductions 2 Fewer shares than last month

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
Divi's Laboratories Limited Healthcare Large Cap 10.21% 39.52 Cr 42,533 by Dec 2024 (22 mo+)
Sun Pharmaceutical Industries Limited Healthcare Large Cap 9.38% 36.30 Cr 0.02 Cr by Dec 2024 (22 mo+)
Piramal Pharma Limited Healthcare Small Cap 6.65% 25.75 Cr 0.12 Cr by Dec 2024 (22 mo+)
Rubicon Research Limited Healthcare Small Cap 6.36% 24.61 Cr 0.02 Cr Oct 2025 (12 mo)
Aurobindo Pharma Limited Healthcare Mid Cap 6.31% 24.43 Cr 0.01 Cr Apr 2025 (18 mo)
Apollo Hospitals Enterprise Limited Healthcare Large Cap 5.77% 22.34 Cr 27,355 by Dec 2024 (22 mo+)
Torrent Pharmaceuticals Limited Healthcare Large Cap 5.00% 19.36 Cr 40,333 Jan 2025 (21 mo)
Emcure Pharmaceuticals Limited Healthcare Small Cap 4.22% 16.33 Cr 84,054 by Dec 2024 (22 mo+)
Laurus Labs Limited Healthcare Mid Cap 4.09% 15.84 Cr 80,000 Mar 2026 (7 mo)
Neuland Laboratories Limited Healthcare Small Cap 3.99% 15.46 Cr 7,242 by Dec 2024 (22 mo+)
Max Healthcare Institute Limited Healthcare Large Cap 3.13% 12.12 Cr 0.01 Cr May 2025 (17 mo)
Alkem Laboratories Limited Healthcare Mid Cap 3.10% 12.00 Cr 23,236 Sep 2026 (1 mo)
Zydus Lifesciences Limited Healthcare Mid Cap 2.69% 10.41 Cr 89,621 May 2026 (5 mo)
IPCA Laboratories Limited Healthcare Mid Cap 2.51% 9.73 Cr 50,483 by Dec 2024 (22 mo+)
Fortis Healthcare Limited Healthcare Mid Cap 2.39% 9.25 Cr 0.01 Cr May 2025 (17 mo)
Zydus Wellness Limited Fast Moving Consumer Goods Small Cap 2.30% 8.90 Cr 0.02 Cr by Dec 2024 (22 mo+)
Vijaya Diagnostic Centre Limited Healthcare Small Cap 2.29% 8.87 Cr 61,718 Jan 2025 (21 mo)
Senores Pharmaceuticals Limited Healthcare Small Cap 2.18% 8.45 Cr 60,946 Apr 2026 (6 mo)
Shaily Engineering Plastics Limited Consumer Durables Small Cap 1.96% 7.60 Cr 24,809 Jan 2025 (21 mo)
Dr. Lal Path Labs Ltd. Healthcare Small Cap 1.81% 7.00 Cr 35,236 Jan 2025 (21 mo)
GlaxoSmithKline Pharmaceuticals Limited Healthcare Mid Cap 1.70% 6.59 Cr 23,792 by Dec 2024 (22 mo+)
Glenmark Pharmaceuticals Limited Healthcare Mid Cap 1.67% 6.48 Cr 27,743 by Dec 2024 (22 mo+)
Dr. Reddy's Laboratories Limited Healthcare Large Cap 1.43% 5.55 Cr 45,000 Jul 2026 (3 mo)
Cipla Limited Healthcare Large Cap 1.39% 5.38 Cr 40,000 Aug 2026 (2 mo)
Sanofi Consumer Healthcare India Limited Not classified Small Cap 1.36% 5.27 Cr 13,863 by Dec 2024 (22 mo+)
Biocon Limited Healthcare Mid Cap 1.10% 4.24 Cr 0.01 Cr by Dec 2024 (22 mo+)
Navin Fluorine International Limited Chemicals Small Cap 0.98% 3.80 Cr 4,610 Feb 2026 (8 mo)
Krishna Institute of Medical Sciences Limited Healthcare Small Cap 0.96% 3.73 Cr 50,000 Feb 2026 (8 mo)
Jubilant Pharmova Limited Healthcare Small Cap 0.93% 3.60 Cr 34,986 Jan 2025 (21 mo)
Onesource Specialty Pharma Limited Healthcare Small Cap 0.86% 3.35 Cr 22,000 Jul 2026 (3 mo)
Medi Assist Healthcare Services Limited Not classified Small Cap 0.79% 3.04 Cr 0.01 Cr Jan 2025 (21 mo)
Neogen Chemicals Limited Chemicals Small Cap 0.24% 0.94 Cr 3,854 Aug 2026 (2 mo)
Sumitomo Chemical India Limited Chemicals Small Cap 0.22% 0.87 Cr 20,000 Jul 2026 (3 mo)

Half of its current holdings have been held for 21 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
Turtlemint Fintech Solutions Limited Sep 2026 ▼ Complete exit -0.03 Cr
Sun Pharmaceutical Industries Limited Sep 2026 ▲ Increasing +32,000
Laurus Labs Limited Sep 2026 ▲ Increasing +30,000
Piramal Pharma Limited Sep 2026 ▼ Reducing -25,000
Alkem Laboratories Limited Sep 2026 ▲ New position +23,236
Divi's Laboratories Limited Sep 2026 ▼ Reducing -2,694
MTAR Technologies Limited Sep 2026 ▼ Complete exit -1,500
Zydus Lifesciences Limited Aug 2026 ▲ Increasing +45,000
Cipla Limited Aug 2026 ▲ New position +40,000
Navin Fluorine International Limited Aug 2026 ▼ Reducing -5,390
Neogen Chemicals Limited Aug 2026 ▲ New position +3,854
Neuland Laboratories Limited Aug 2026 ▼ Reducing -1,500
Medplus Health Services Limited Jul 2026 ▼ Complete exit -51,652
Sun Pharmaceutical Industries Limited Jul 2026 ▲ Increasing +47,000
Dr. Reddy's Laboratories Limited Jul 2026 ▲ New position +45,000
Eris Lifesciences Limited Jul 2026 ▼ Complete exit -25,000
Onesource Specialty Pharma Limited Jul 2026 ▲ New position +22,000
Sumitomo Chemical India Limited Jul 2026 ▲ New position +20,000
AstraZeneca Pharma India Limited Jul 2026 ▼ Complete exit -3,267
Abbott India Limited Jul 2026 ▼ Complete exit -1,738
Turtlemint Fintech Solutions Limited Jun 2026 ▲ New position +0.03 Cr
ICICI Prudential Life Insurance Company Limited Jun 2026 ▼ Complete exit -60,000
Piramal Pharma Limited Jun 2026 ▲ Increasing +19,622
Max Healthcare Institute Limited Jun 2026 ▲ Increasing +3,491
Rubicon Research Limited Jun 2026 ▲ Increasing +2,563
Aurobindo Pharma Limited Jun 2026 ▲ Increasing +2,363
Emcure Pharmaceuticals Limited Jun 2026 ▲ Increasing +2,052
MTAR Technologies Limited Jun 2026 ▼ Reducing -1,000
Torrent Pharmaceuticals Limited Jun 2026 ▲ Increasing +708
Zydus Lifesciences Limited Jun 2026 ▼ Reducing -379
Neuland Laboratories Limited Jun 2026 ▲ Increasing +203
Emami Limited May 2026 ▼ Complete exit -64,782
ICICI Prudential Life Insurance Company Limited May 2026 ▲ New position +60,000
Godrej Consumer Products Limited May 2026 ▼ Complete exit -50,000
Zydus Lifesciences Limited May 2026 ▲ New position +45,000
Sun Pharmaceutical Industries Limited May 2026 ▼ Reducing -40,000
Senores Pharmaceuticals Limited May 2026 ▲ Increasing +30,824
Lupin Limited May 2026 ▼ Complete exit -20,256
Aurobindo Pharma Limited May 2026 ▼ Reducing -9,049
MTAR Technologies Limited May 2026 ▲ New position +2,500
Senores Pharmaceuticals Limited Apr 2026 ▲ New position +30,122
Laurus Labs Limited Mar 2026 ▲ New position +50,000
Alembic Pharmaceuticals Limited Mar 2026 ▼ Complete exit -39,947
TATA CONSUMER PRODUCTS LIMITED Mar 2026 ▼ Complete exit -30,000
Cipla Limited Mar 2026 ▼ Complete exit -23,706
Lupin Limited Mar 2026 ▼ Reducing -16,022
Kwality Wall's (India) Limited Mar 2026 ▼ Complete exit -15,581
Hindustan Unilever Limited Mar 2026 ▼ Complete exit -15,581
Zydus Wellness Limited Mar 2026 ▲ Increasing +10,000
Sun Pharmaceutical Industries Limited Mar 2026 ▲ Increasing +8,590
Neuland Laboratories Limited Mar 2026 ▲ Increasing +200
Piramal Pharma Limited Feb 2026 ▲ Increasing +0.05 Cr
ETERNAL LIMITED Feb 2026 ▼ Complete exit -0.02 Cr
Max Healthcare Institute Limited Feb 2026 ▲ Increasing +91,875
Biocon Limited Feb 2026 ▼ Reducing -75,000
Cipla Limited Feb 2026 ▼ Reducing -62,721
Krishna Institute of Medical Sciences Limited Feb 2026 ▲ New position +50,000
Rainbow Childrens Medicare Limited Feb 2026 ▼ Complete exit -29,503
Torrent Pharmaceuticals Limited Feb 2026 ▲ Increasing +29,299
Eris Lifesciences Limited Feb 2026 ▲ New position +25,000
Glenmark Pharmaceuticals Limited Feb 2026 ▼ Reducing -16,080
Zydus Wellness Limited Feb 2026 ▲ Increasing +14,887
Pfizer Limited Feb 2026 ▼ Complete exit -13,314
Navin Fluorine International Limited Feb 2026 ▲ New position +10,000
Syngene International Limited Jan 2026 ▼ Complete exit -55,139
Marico Limited Jan 2026 ▼ Complete exit -31,592
Cipla Limited Jan 2026 ▼ Reducing -25,484
Mankind Pharma Limited Jan 2026 ▼ Complete exit -14,526
Zydus Wellness Limited Jan 2026 ▲ Increasing +10,718
Biocon Limited Dec 2025 ▼ Reducing -0.01 Cr
ETERNAL LIMITED Dec 2025 ▲ Increasing +0.01 Cr
Rubicon Research Limited Dec 2025 ▲ Increasing +21,800
Kwality Wall's (India) Limited Dec 2025 ▲ New position +15,581
Glenmark Pharmaceuticals Limited Dec 2025 ▲ Increasing +8,160
GlaxoSmithKline Pharmaceuticals Limited Dec 2025 ▲ Increasing +2,845
Divi's Laboratories Limited Dec 2025 ▲ Increasing +1,291
Piramal Pharma Limited Nov 2025 ▲ Increasing +0.03 Cr
ETERNAL LIMITED Nov 2025 ▲ New position +87,500
Aurobindo Pharma Limited Nov 2025 ▲ Increasing +59,123
Dr. Reddy's Laboratories Limited Nov 2025 ▼ Complete exit -50,243
TATA CONSUMER PRODUCTS LIMITED Nov 2025 ▲ New position +30,000
Cohance Lifesciences Limited Nov 2025 ▼ Complete exit -11,985
Dr. Lal Path Labs Ltd. Nov 2025 ▼ Reducing -10,337
Emami Limited Nov 2025 ▲ Increasing +9,783
Neogen Chemicals Limited Nov 2025 ▼ Complete exit -9,432
Alkem Laboratories Limited Nov 2025 ▼ Complete exit -8,185
Rubicon Research Limited Oct 2025 ▲ New position +0.01 Cr
Dr. Reddy's Laboratories Limited Oct 2025 ▼ Reducing -40,192
Nestle India Limited Oct 2025 ▼ Complete exit -13,892
Glenmark Pharmaceuticals Limited Oct 2025 ▼ Reducing -13,298
PB Fintech Limited Oct 2025 ▼ Complete exit -9,836
Fortis Healthcare Limited Oct 2025 ▼ Reducing -7,227
Dr. Lal Path Labs Ltd. Oct 2025 ▼ Reducing -5,506
Cipla Limited Oct 2025 ▼ Reducing -4,899
Pfizer Limited Oct 2025 ▼ Reducing -3,004
Torrent Pharmaceuticals Limited Oct 2025 ▼ Reducing -2,363
Alkem Laboratories Limited Oct 2025 ▼ Reducing -1,370
Syngene International Limited Sep 2025 ▼ Reducing -0.01 Cr
Emami Limited Sep 2025 ▼ Reducing -20,346
Biocon Limited Sep 2025 ▲ Increasing +12,000

Changes compare consecutive month-end disclosures for this portfolio only.